IGEA Pharma N.V. Becomes the 12th New Listing at SIX in 2018

Today, the shares of IGEA Pharma N.V. (IGPH) were listed under the “International Reporting Standard” on the Swiss Stock Exchange.

Published at
Medium
Media

The share capital of IGEA Pharma N.V. comprises 25,048,769 shares with a nominal value of EUR 0.01 each. The opening price was CHF 3.75 per share, corresponding to a market capitalization of around CHF 94 million. An offering of the company’s shares has not taken place.

IGEA Pharma N.V. is a life sciences company with its corporate headquarters in Amsterdam in the Netherlands. The IGEA Group focuses on products and services related to the prevention of Alzheimer's and Type II Diabetes. For more information on the company, please visit: www.igeapharma.nl

Any questions?

Please do not hesitate to contact Julian Chan.

Generate PDF

 
About SIX
SIX serves the Swiss and Spanish financial centers and a broad international client base, offering stable and efficient infrastructure services. SIX operates stock exchanges and provides services in securities, financial information as well as the payments business. The company is owned by its users (about 120 financial institutions). With over 4,400 employees and a presence in 19 countries, SIX generated operating income of CHF 1.6 billion and EBITDA of CHF 443.7 million in 2024.
www.six-group.com

View all Media Releases